Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (101-110 of 350) with videos related to

Pageof 35
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|June 27, 2013
Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell deathIsabelle Vanessa Mohrenz, Patrick Antonietti, Stefan Pusch, et al.
Journal of Neuro-Oncology|April 25, 2012
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomasRezvan Ahmadi, Florian Stockhammer, Natalia Becker, et al.
Acta Neuropathologica Communications|June 14, 2024
Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomasFelix Ehret, Eilís Perez, Daniel Teichmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumorsAlon D Altman, Gregg S Nelson, Prafull Ghatage, et al.
Brain Pathology (Zurich, Switzerland)|June 6, 2020
cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumorsDavid W Ellison, Kenneth D Aldape, David Capper, et al.
Journal of Neuroscience Research|March 6, 2007
Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survivalArne Warth, Perikles Simon, David Capper, et al.
Acta Neuropathologica Communications|May 9, 2024
Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomasFelix Ehret, Eilís Perez, Daniel Teichmann, et al.
Acta Neuropathologica|November 20, 2010
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomasChristian Hartmann, Bettina Hentschel, Wolfgang Wick, et al.
The EMBO Journal|April 19, 2012
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signallingMichael Röring, Ricarda Herr, Gina J Fiala, et al.
Acta Neuropathologica|March 3, 2018
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutantDavid N Louis, Caterina Giannini, David Capper, et al.
Pageof 35

Showing results (101-110 of 350) with videos related to

Sort By:
Pageof 35
Apoptosis : an International Journal on Programmed Cell Death|June 27, 2013
Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell deathIsabelle Vanessa Mohrenz, Patrick Antonietti, Stefan Pusch, et al.
Journal of Neuro-Oncology|April 25, 2012
No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomasRezvan Ahmadi, Florian Stockhammer, Natalia Becker, et al.
Acta Neuropathologica Communications|June 14, 2024
Correction: Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomasFelix Ehret, Eilís Perez, Daniel Teichmann, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 6, 2013
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumorsAlon D Altman, Gregg S Nelson, Prafull Ghatage, et al.
Brain Pathology (Zurich, Switzerland)|June 6, 2020
cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumorsDavid W Ellison, Kenneth D Aldape, David Capper, et al.
Journal of Neuroscience Research|March 6, 2007
Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survivalArne Warth, Perikles Simon, David Capper, et al.
Acta Neuropathologica Communications|May 9, 2024
Clinical implications of DNA methylation-based integrated classification of histologically defined grade 2 meningiomasFelix Ehret, Eilís Perez, Daniel Teichmann, et al.
Acta Neuropathologica|November 20, 2010
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomasChristian Hartmann, Bettina Hentschel, Wolfgang Wick, et al.
The EMBO Journal|April 19, 2012
Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signallingMichael Röring, Ricarda Herr, Gina J Fiala, et al.
Acta Neuropathologica|March 3, 2018
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutantDavid N Louis, Caterina Giannini, David Capper, et al.
Pageof 35